Cell Therapy News Volume 23.42 | Dec 12 2022

    0
    33








    2022-12-12 | CTN 23.42


    Cell Therapy News by STEMCELL Technologies
    Vol. 23.42 – 12 December, 2022
    TOP STORY

    Expression of Inducible Factors Reprograms CAR-T Cells for Enhanced Function and Safety

    Researchers developed a genetic platform that combined autonomous antigen-induced production of an accessory molecule with constitutive CAR expression in a single lentiviral vector called Uni-Vect.
    [Cancer Cell]

    AbstractGraphical Abstract
    Request your free copy of the 'Frequencies of Cell Types in Human Peripheral Blood' Wallchart
    PUBLICATIONSRanked by the impact factor of the journal

    Optimization of the Proliferation and Persistency of CAR T Cells Derived from Human Induced Pluripotent Stem Cells

    Scientists showed that the proliferation of CD8αβ cytotoxic CAR T cells in solid tumours could be enhanced by deriving and expanding them from a single human induced-pluripotent-stem-cell clone bearing a CAR selected for efficient differentiation.
    [Nature Biomedical Engineering]

    Full Article

    Scar-Degrading Endothelial Cells as a Treatment for Advanced Liver Fibrosis

    In vivo, single intrasplenic injection of degrading liver sinusoidal endothelial cells (dLSECs) alleviated advanced liver fibrosis in mice, while intraperitoneal administration of liver-targeting peptide-modified dLSECs showed enhanced fibrosis-targeting effects.
    [Advanced Science]

    Full Article

    Single-Cell and Spatial Transcriptomics Decodes Wharton’s Jelly-Derived Mesenchymal Stem Cells Heterogeneity and a Subpopulation with Wound Repair Signatures

    The characteristics of Wharton’s jelly mesenchymal stem cells (MSCs) were systematically analyzed by single cell and spatial transcriptome sequencing. Additionally, the biofunctional-type MSCs selected in this study exhibited promising wound repair properties.
    [Advanced Science]

    Full Article

    Engineered Neural Tissue Made Using Hydrogels Derived from Decellularised Tissues for the Regeneration of Peripheral Nerves

    Decellularisation was carried out on bone, liver, and small intestinal tissues and the resultant decellularised materials were biochemically and mechanically characterized.
    [Acta Biomaterialia]

    Full ArticleGraphical Abstract

    Cryopreserved Anti-CD22 and Bispecific Anti-CD19/22 CAR T Cells Are as Effective as Freshly Infused Cells

    Among 40 patients who received anti-CD22 CAR T-cells there were no differences in in vivo expansion, persistence, incidence of toxicities, or disease response between groups with cryopreserved and fresh CAR T-cells.
    [Molecular Therapy-Methods & Clinical Development]

    AbstractGraphical Abstract

    Endothelial Activation Predicts Disseminated Intravascular Coagulopathy, Cytokine Release Syndrome and Prognosis in Patients Treated with Anti-CD19 CAR-T Cells

    In 38 consecutive patients with aggressive lymphoproliferative disease investigators measured a coagulative laboratory panel at baseline and early after infusion of anti-CD19 CAR-T.
    [British Journal of Haematology]

    Full Article

    Hair Follicle Associated Pluripotent (HAP) Stem Cells Jump from Transplanted Whiskers to Pelage Follicles and Stimulate Hair Growth

    The upper part of vibrissa follicles from nestin-driven green-fluorescent protein (GFP) transgenic mice, containing GFP-expressing HAP stem cells, were transplanted in the dorsal area of athymic nude mice.
    [Scientific Reports]

    Full Article

    Development of Minimally Invasive Cancer Immunotherapy Using Anti-Disialoganglioside GD2 Antibody-Producing Mesenchymal Stem Cells for a Neuroblastoma Mouse Model

    Mouse IgG anti-disialoganglioside GD2 antibody-secreting mouse mesenchymal stem cells were developed, and their anti-tumor effects were validated in an in vivo neuroblastoma mouse model.
    [Pediatric Surgery International]

    Abstract
    ON903-COVID-19 Digital Resources 728 x 90
    REVIEWS

    MSC Based Gene Delivery Methods and Strategies Improve the Therapeutic Efficacy of Neurological Diseases

    Investigators focus on gene transport technologies for engineering MSCs and the application of strategies for selecting optimal delivery genes.
    [Bioactive Materials]

    Full ArticleGraphical Abstract

    Engineering Chimeric Antigen Receptor T Cells for Solid Tumour Therapy

    Scientists discuss tumor microenvironment-associated aspects with an emphasis on T cell trafficking, extracellular matrix barriers, abnormal vasculature, solid tumor heterogenicity, and immune suppressive microenvironment.
    [Clinical and Translational Medicine]

    Full Article

    Strategies to Capitalize on Cell Spheroid Therapeutic Potential for Tissue Repair and Disease Modeling

    The authors describe the current state of preclinical spheroid research and highlight two key examples of spheroid use in clinically relevant disease modeling.
    [npj Regenerative Medicine]

    Full Article
    INDUSTRY AND POLICY NEWS

    Autolus Therapeutics Announces Pivotal Phase II FELIX Clinical Trial Has Met Primary Endpoint at Interim Analysis

    Autolus Therapeutics plc announced that the Phase II pivotal FELIX clinical trial of obecabtagene autoleucel in relapsed/refractory adult acute lymphoblastic leukemia has met its primary endpoint as verified by an independent data monitoring committee.
    [Autolus Therapeutics plc]

    Press Release
    FEATURED EVENT

    Stem Cells: Advances in the Application of Stem Cells and Their Role In Vivo

    February 5 – 8, 2023
    Keystone, Colorado, United States

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Scholar – Glioblastoma Tumor Growth

    University of California Irvine – Irvine, California, United States

    Postdoctoral Fellow – CAR T Cells

    NYU Langone Medical Center – New York, New York, United States

    Tenure Track Positions – Precision Oncology and Immuno-Oncology

    Medical College of Wisconsin – Milwaukee, Wisconsin, United States

    PhD Positions – Biomedical Sciences

    Max Delbrück Center for Molecular Medicine – Berlin-Buch, Germany

    Clinical Development Medical Director – Oncology & Hematology

    Novartis – East Hanover, New Jersey, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Cell Therapy News Twitter